3-183920057-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_005688.4(ABCC5):c.*1243A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.526 in 152,546 control chromosomes in the GnomAD database, including 21,757 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.53 ( 21713 hom., cov: 33)
Exomes 𝑓: 0.44 ( 44 hom. )
Consequence
ABCC5
NM_005688.4 3_prime_UTR
NM_005688.4 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.697
Genes affected
ABCC5 (HGNC:56): (ATP binding cassette subfamily C member 5) The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This protein functions in the cellular export of its substrate, cyclic nucleotides. This export contributes to the degradation of phosphodiesterases and possibly an elimination pathway for cyclic nucleotides. Studies show that this protein provides resistance to thiopurine anticancer drugs, 6-mercatopurine and thioguanine, and the anti-HIV drug 9-(2-phosphonylmethoxyethyl)adenine. This protein may be involved in resistance to thiopurines in acute lymphoblastic leukemia and antiretroviral nucleoside analogs in HIV-infected patients. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.654 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ABCC5 | ENST00000334444 | c.*1243A>G | 3_prime_UTR_variant | Exon 30 of 30 | 1 | NM_005688.4 | ENSP00000333926.6 | |||
ABCC5 | ENST00000265586 | c.*1243A>G | 3_prime_UTR_variant | Exon 29 of 29 | 5 | ENSP00000265586.6 | ||||
ABCC5 | ENST00000437205.5 | n.*4250A>G | non_coding_transcript_exon_variant | Exon 30 of 30 | 5 | ENSP00000403510.1 | ||||
ABCC5 | ENST00000437205.5 | n.*4250A>G | 3_prime_UTR_variant | Exon 30 of 30 | 5 | ENSP00000403510.1 |
Frequencies
GnomAD3 genomes AF: 0.527 AC: 80027AN: 151996Hom.: 21678 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
80027
AN:
151996
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.440 AC: 190AN: 432Hom.: 44 Cov.: 0 AF XY: 0.431 AC XY: 106AN XY: 246 show subpopulations
GnomAD4 exome
AF:
AC:
190
AN:
432
Hom.:
Cov.:
0
AF XY:
AC XY:
106
AN XY:
246
Gnomad4 AFR exome
AC:
0
AN:
0
Gnomad4 AMR exome
AC:
0
AN:
0
Gnomad4 ASJ exome
AC:
0
AN:
0
Gnomad4 EAS exome
AC:
0
AN:
0
Gnomad4 SAS exome
AC:
0
AN:
0
Gnomad4 FIN exome
AF:
AC:
180
AN:
414
Gnomad4 NFE exome
AF:
AC:
7
AN:
12
Gnomad4 Remaining exome
AF:
AC:
3
AN:
6
Heterozygous variant carriers
0
4
9
13
18
22
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.527 AC: 80112AN: 152114Hom.: 21713 Cov.: 33 AF XY: 0.519 AC XY: 38579AN XY: 74358 show subpopulations
GnomAD4 genome
AF:
AC:
80112
AN:
152114
Hom.:
Cov.:
33
AF XY:
AC XY:
38579
AN XY:
74358
Gnomad4 AFR
AF:
AC:
0.660602
AN:
0.660602
Gnomad4 AMR
AF:
AC:
0.486384
AN:
0.486384
Gnomad4 ASJ
AF:
AC:
0.446367
AN:
0.446367
Gnomad4 EAS
AF:
AC:
0.503096
AN:
0.503096
Gnomad4 SAS
AF:
AC:
0.439419
AN:
0.439419
Gnomad4 FIN
AF:
AC:
0.400113
AN:
0.400113
Gnomad4 NFE
AF:
AC:
0.4861
AN:
0.4861
Gnomad4 OTH
AF:
AC:
0.542694
AN:
0.542694
Heterozygous variant carriers
0
1940
3880
5821
7761
9701
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
690
1380
2070
2760
3450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1756
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at